Skip to content

Contact

FIP Development Goals

Transforming global pharmacy

About the Goals
1 Academic Capacity 2 Early Career Training Strategy 3 Quality Assurance 4 Advanced and Specialist Development 5 Competency Development 6 Leadership Development 7 Advancing Integrated Services 8 Working With Others 9 Continuing Professional Development Strategies 10 Equity & Equality 11 Impact & Outcomes 12 Pharmacy Intelligence 13 Policy Development 14 Medicines Expertise 15 People-Centred Care 16 Communicable Diseases 17 Antimicrobial Stewardship 18 Access to Medicines, Devices & Services 19 Patient Safety 20 Digital Health 21 Sustainability in Pharmacy
Global Roadmap 2030
Resources
Global Report 2021

FIP Statement of Policy: Pharmacist’s Authority in Product Selection Therapeutic Interchange and Generic Substitution (1997)

FIP Statement of Policy: Pharmacist’s Authority in Product Selection Therapeutic Interchange and Generic Substitution (1997)

Post navigation

146th EXECUTIVE BOARD: Intervention on provisional agenda item 6. Primary health care (2020)

73rd World Health Assembly: Intervention on provisional agenda item 11.1. Primary health care (2020)

Follow us

FIP works for

Pharmacy practitioners
Pharmaceutical scientists
Pharmaceutical educators
Young pharmacists and new graduates

Shortcuts

About the Goals
Global Roadmap 2030
Global Report 2021

Our contact details FIP Development Goals
Andries Bickerweg 5
2517 JP The Hague
Netherlands

E: [email protected]

Chamber of Commerce: 40410354
VAT no.: NL00.28.75.378.B.01

© Copyright International Pharmaceutical Federation 2025

Privacy statement
Disclaimer
Scroll to top